Previous Article | Next Article 
Molecular and Cellular Biology, April 2000, p. 2670-2675, Vol. 20, No. 8
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Disruption of Heat Shock Factor 1 Reveals an
Essential Role in the Ubiquitin Proteolytic Pathway
Lila
Pirkkala,1,2
Tero-Pekka
Alastalo,1,3
XiaoXia
Zuo,4
Ivor J.
Benjamin,4,* and
Lea
Sistonen1,*
Turku Centre for Biotechnology, University of
Turku, Åbo Akademi University,1
Department of Biology, Åbo Akademi
University,2 and Department of Anatomy,
University of Turku,3 FIN-20521 Turku, Finland,
and Department of Internal Medicine, University of Texas
Southwestern Medical Center at Dallas, Dallas, Texas
75235-85734
Received 7 September 1999/Returned for modification 12 October
1999/Accepted 13 January 2000
 |
ABSTRACT |
Inhibition of proteasome-mediated protein degradation machinery is
a potent stress stimulus that causes accumulation of ubiquitinated proteins and increased expression of heat shock proteins (Hsps). Hsps
play pivotal roles in homeostasis and protection in a cell, through
their well-recognized properties as molecular chaperones. The inducible
Hsp expression is regulated by the heat shock transcription factors
(HSFs). Among mammalian HSFs, HSF1 has been shown to be important for
regulation of the heat-induced stress gene expression, whereas the
function of HSF2 in stress response is unclear. Recent reports have
suggested that both HSF1 and HSF2 are affected during down-regulation
of ubiquitin-proteasome pathway (Y. Kawazoe et al., Eur. J. Biochem. 255:356-362, 1998; A. Mathew et al., Mol. Cell. Biol.
18:5091-5098, 1998; D. Kim et al., Biochem. Biophys. Res. Commun.
254:264-268, 1999). To date, however, no unambiguous evidence has been
presented as to whether a single specific HSF or multiple members of
the HSF family are required for transcriptional induction of heat shock
genes when proteasome activity is down-regulated. Therefore, by using
loss-of-function and gain-of-function strategies, we investigated the
specific roles of mammalian HSFs in regulation of the
ubiquitin-proteasome-mediated stress response. Here we demonstrate that
HSF1, but not HSF2, is essential and sufficient for up-regulation of
Hsp70 expression during down-regulation of the ubiquitin proteolytic
pathway. We propose that specificity of HSF1 could be an important
therapeutic target during disease pathogenesis associated with abnormal
ubiquitin-dependent proteasome function.
 |
INTRODUCTION |
Regulation of protein degradation by
the ubiquitin-proteasome pathway enables cells rapidly to reduce levels
of defined proteins that control diverse processes, such as gene
expression, cell signaling, immune responses, and stress adaptation.
Therefore, proteasome-mediated degradation has to display a high degree
of specificity, carried out by complex cascades of enzymes, toward its
numerous substrates (6). Recently, a variety of inhibitors of the 26S proteasome have been identified. For example, the peptide aldehyde MG132 and the natural products lactacystin and its derivative clasto-lactacystin
-lactone all selectively inhibit
degradation of proteins by the ubiquitin-proteasome pathway
(15).
When the ubiquitin-proteasome network is down-regulated, certain heat
shock proteins, such as Hsp70, and other molecular chaperones are
induced (5, 13, 14, 21, 22, 45). Expression of heat shock
genes is regulated at the transcriptional level by activation of the
heat shock transcription factors (HSFs) (25, 42). Unlike in
yeast and Drosophila, the existence of multiple HSFs in
eukaryotes suggests that the various HSFs might have specialized functions in response to distinct physiological and environmental stimuli. Among the three known mammalian HSFs (HSF1, HSF2, and HSF4),
HSF1 mediates the stress response induced by heat, heavy metals, and
oxidants, while HSF2 has been suggested to have a role as a
developmental regulator (1, 2, 23, 31, 32, 34, 35, 37, 38),
and the role of HSF4 is still unknown (27). Recently, the
phenotype of homozygous HSF1-deficient
(hsf1
/
) mice was reported to include defects
of the chorioallantoic placenta and increased prenatal lethality,
growth retardation, female infertility, elimination of the classical
heat shock response, and exaggerated tumor necrosis factor alpha
production, which results in increased mortality after endotoxin
challenge (43). These results demonstrate that, in addition
to regulation of the stress response under pathological conditions,
HSF1 is required for extraembryonic development and postnatal growth.
The specific functions of HSF1 and HSF2 in the regulation of heat shock
gene expression in response to distinct stimuli, and especially during
down-regulation of proteasome activity, are unclear. Mathew and
coworkers (21) have provided evidence for the activation and
accumulation of HSF2 when the ubiquitin-proteasome pathway is
down-regulated, whereas all of the three avian HSFs have been shown to
be activated by proteasome inhibitors; consequently, all of the major
Hsps are markedly induced (13). Furthermore, Kim and
coworkers (14) have suggested that treatments with MG132 and
lactacystin result in altered phosphorylation state and activation of
the DNA-binding ability of HSF1 in mouse cells. These findings raise
the question of whether both HSF1 and HSF2 regulate heat shock
gene expression in the ubiquitin proteolytic pathway.
To establish the specific roles of HSF1 and HSF2 in regulation of the
ubiquitin-proteasome network, we used loss-of-function and
gain-of-function strategies. In this study, by using HSF1-deficient cells, we show that the induction of heat shock response upon proteasome inhibition requires HSF1, as measured by increased Hsp70
expression, and this property cannot be substituted by other HSFs.
Moreover, reintroduction of the HSF1 gene into HSF1-deficient cells
containing normal HSF2 expression can restore the inducible Hsp70
expression in response to down-regulation of the ubiquitin-proteasome pathway. Our results provide compelling evidence for HSF1, not HSF2,
being the critical transcription factor for heat shock gene expression
following proteasome inhibition.
 |
MATERIALS AND METHODS |
Cell culture and experimental treatments.
Human K562
erythroleukemia cells were maintained in RPMI 1640 medium supplemented
with 10% fetal calf serum (FCS) and antibiotics (penicillin and
streptomycin) in a humidified 5% CO2 atmosphere at 37°C.
K562 cells stably overexpressing HSF2-
and HSF2-
isoforms (2
-C7 and 2
-D5, respectively [17]) were
maintained in RPMI 1640 medium containing G418 (500 µg/ml;
Gibco/BRL). Mouse embryonic fibroblasts (MEF cells) from wild-type and
HSF1-deficient mice (24) were maintained in Dulbecco's
modified Eagle's medium containing 10% FCS, 10 mM minimal essential
medium nonessential amino acids, 0.96 µl of
-mercaptoethanol per
100 ml, and antibiotics (penicillin and streptomycin). For experimental
treatments, cells were seeded at 5 × 106 cells per
10-cm-diameter plate (HSF2-
- and HSF2-
-overexpressing cells were
plated in RPMI 1640 medium without G418). Hemin (Aldrich) was added to
a final concentration of 40 µM, MG132 (Peptide Institute, Inc.) was
added to 10 µM, and clasto-lactacystin
-lactone
(Calbiochem) was added to 5 and 10 µM; cells were then incubated at
37°C for the indicated time periods. Heat shock was performed at
42°C in a water bath.
Plasmid constructions.
A full-length 1,974-bp cDNA coding
for mouse HSF1 (clone C12A) was digested from pGEM-1 vector
(34) and subcloned under the cytomegalovirus promoter into
the EcoRI site of pCI vector (Promega). Flag-tagged mouse
HSF1 was a kind gift from Richard Morimoto (Northwestern University,
Evanston, Ill.). Flag-tagged mouse HSF2-
and HSF2-
expression
plasmids were constructed by PCR using forward
(5'-CGGAATTCCAACGTGCCGGCTTTC-3') and reverse (5'-CCATCGATTCCACTTGGGAG-3') primers. The
forward primer contains an EcoRI restriction site consensus
sequence (underlined), and the reverse primer contains a
ClaI restriction site (underlined). The resulting
EcoRI and ClaI sites were used to clone the
fragment in frame with the Flag tag in pFLAG-CMV-2 (Kodak).
Transfections.
MEF cells were transfected by electroporation
(975 µF, 280 V) using a Bio-Rad Gene Pulser electroporator. Cells
(2 × 106) were washed, resuspended in 0.4 ml of
OptiMEM (Gibco-BRL), and placed in a 0.4-cm gap electroporation cuvette
(BTX). Plasmid DNA (30 µg) was added, and after a brief incubation at
room temperature, the cells were subjected to a single electric pulse
followed by dilution to 2 × 105 cells/ml with
Dulbecco's modified Eagle's medium containing 10% FCS, 10 mM minimal
essential medium nonessential amino acids, 0.96 µl of
-mercaptoethanol per 100 ml, and antibiotics (penicillin and
streptomycin). Thereafter, cells were incubated at 37°C for 40 h
prior to use.
Gel mobility shift assay.
Whole cell extracts were
prepared from treated cells as previously described (26) and
incubated (12 µg of protein) with a 32P-labeled
oligonucleotide representing the proximal heat shock element (HSE) of
the human hsp70 promoter. The protein-DNA complexes were
analyzed on a native 4% polyacrylamide gel as described previously (26). The signal intensities of the protein-DNA complexes
were quantitated with a phosphorimaging scanner (Bio-Rad).
Nuclear run-on assay.
Nuclear run-on transcription
reactions were performed with nuclei isolated from MG132-, hemin-, or
heat shock-treated cells in the presence of 100 µCi of
[
-32P]dUTP (3,000 Ci/mmol; Amersham) as previously
described (3). Radiolabeled RNA was hybridized to
nitrocellulose-immobilized plasmids for the human hsp70
(pH2.3 [41]), human hsp90/89
(pUCHS801 [11]), and rat GAPDH (pGAPDH
[9]) genes and a Bluescript vector (Stratagene). The
hybridizations were carried out in 50% formamide-6× SSC (1× SSC is
0.15 M sodium chloride and 0.015 M sodium citrate)-10× Denhardt's
solution-0.2% sodium dodecyl sulfate (SDS) at 42°C for 72 h.
Filters were washed with high-stringency conditions (0.2× SSC-0.2%
SDS at 65°C) and visualized by autoradiography.
Western analysis.
Whole cell extracts (12 µg of protein)
were subjected to SDS-8% polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose filter (Protran
nitrocellulose; Schleicher & Schuell) by using a Bio-Rad semidry
transfer apparatus. Proteins were detected as follows: HSF1 by a
polyclonal antibody specific to mouse HSF1 (35), HSF2 by a
polyclonal antibody specific to mouse HSF2 (35), the
inducible form of Hsp70 by 4g4 (Affinity Bioreagents, Inc.), the mouse
Hsp70 by SPA-810 (StressGen), Hsp90 by SPA-835 (StressGen), Hsc70 by
SPA-815 (StressGen), Flag epitope by M2 (Sigma), and actin by
monoclonal antiactin antibody N350 (Amersham). Horseradish
peroxidase-conjugated secondary antibodies were purchased from Promega
and Amersham. The blots were developed with an enhanced
chemiluminescence method (ECL kit; Amersham).
Northern analysis.
Poly(A) mRNA was isolated from the
treated K562 cells by using a poly(A) mRNA purification kit
(Pharmacia). RNA was separated on a 1% agarose-formaldehyde gel,
transferred to a nylon filter (Hybond-N; Amersham), and hybridized at
65°C with an [
-32P]dCTP (50 µCi, 3,000 Ci/mmol;
ICN)-labeled 931-bp HindIII/PstI cDNA insert
coding for human HSF2 (31) (hHSF2 cDNA was a kind gift from
Robert Kingston, Harvard Medical School, Boston, Mass. [37]) and [
-32P]dCTP-labeled plasmids
for human hsp70 (pH2.3 [41]) and rat GAPDH (pGAPDH [9]). Following
hybridization, filters were washed with high-stringency conditions
(0.1× SSC-0.1% SDS at 65°C) and visualized by autoradiography. The
intensities of radioactive signals were quantitated with a
phosphorimaging scanner (Bio-Rad).
 |
RESULTS |
Inhibition of the ubiquitin-proteasome pathway leads to rapid
transcriptional induction of heat shock genes.
To investigate the
HSF DNA-binding activity during down-regulation of the
ubiquitin-proteasome pathway in human K562 erythroleukemia cells, gel
mobility shift analysis was performed with an HSE-containing oligonucleotide. As shown in Fig. 1A, the
HSF HSE binding induced by heat shock and MG132 was readily detectable
after 1 h of treatment. In contrast to the heat-induced HSF HSE
binding, which had totally disappeared after 6 h of heat shock,
the MG132-induced HSF HSE binding remained constant or even increased
during the 6-h period. Similar results were obtained using
clasto-lactacystin
-lactone, a specific covalent
inhibitor of the 26S proteasome. This confirms that the MG132-induced
HSF HSE-binding activity is due to inhibition of proteasome function.
In comparison to the effects of potent proteasome inhibitors, the
hemin-induced HSF HSE binding was detected only after a 6-h treatment,
whereafter it increased until 24 h (Fig. 1A), in agreement with
earlier studies showing a slow and sustained HSF activation related to
erythroid differentiation of K562 cells (38, 40).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Heat shock response caused by inhibition of the
ubiquitin-mediated proteolysis (A) HSF HSE-binding activity in whole
cell extracts from control (C), heat-shocked (HS; 42°C for 1 and
6 h), hemin-treated (40 µM for 6, 16, and 24 h),
MG132-treated (10 µM for 1, 3, 6, and 8 h), and
clasto-lactacystin -lactone-treated (10 or 5 µM for 3 and 8 h) K562 cells was analyzed by gel mobility shift assay.
Extracts (12 µg) were incubated with a 32P-labeled
oligonucleotide representing the proximal HSE of the human
hsp70 promoter. Protein-DNA complexes were resolved on a 4%
nondenaturing polyacrylamide gel as described elsewhere
(26). (B) Transcription rates of hsp70 and
hsp90 genes were analyzed by nuclear run-on assay. Equal
number of nuclei from control (C), heat-shocked (HS; 1 and 6 h at
42°C), hemin-treated (40 µM for 6, 16, and 24 h), and
MG132-treated (10 µM for 1, 3, and 6 h) K562 cells were used for
in vitro [32P]dUTP labeling of newly synthesized
transcripts which were hybridized to immobilized DNA probes for human
hsp70, human hsp90/89 , rat GAPDH,
and a Bluescript vector (BS) as described elsewhere (3).
GAPDH was used as an internal control. (C and D) For protein
analysis, whole cell extracts (12 µg) isolated from control (C),
MG132-treated (10 µM for 3, 8, and 16 h), heat-shocked (HS;
42°C for 1 and 4 h), hemin-treated (40 µM for 8, 16, and
24 h), and clasto-lactacystin -lactone-treated (10 µM for 3 and 8 h) K562 cells were analyzed by SDS-PAGE and
Western immunoblotting using antibodies against HSF1, HSF2, Hsp70,
Hsp90, Hsc70, and actin. (E) Poly(A) mRNA from control (C) and
MG132-treated (10 µM for 2, 4, 6, and 8 h) K562 cells was
analyzed by Northern blotting using 32P-labeled cDNA probes
for human HSF2, hsp70, and GAPDH.
GAPDH was used as a control for equal loading. mRNA sizes are
indicated on the right.
|
|
Since exposure to elevated temperatures is a well-known inducer of heat
shock gene expression, we examined whether the proteasome inhibition-induced HSF HSE binding is accompanied by enhanced transcription of heat shock genes. The nuclear run-on experiment shown
in Fig. 1B demonstrates that similarly to heat shock, the proteasome
inhibitor MG132 strongly induced hsp70 and to a lesser extent hsp90 transcription after 1 h. In agreement with
the HSE-binding activity (Fig. 1A), heat shock stimulated
hsp70 and hsp90 transcription transiently,
whereas the MG132-induced transcription persisted for at least 6 h
(Fig. 1B). In contrast to the prominent transcriptional induction of
hsp70 gene in response to heat stress and blocked proteasome
function, hsp70 transcription was significantly less affected by hemin treatment (Fig. 1B). Next, we measured heat shock
protein accumulation in response to proteasome inhibition, heat shock,
and hemin treatment. Hsp70 protein levels dramatically increased by
8 h of treatment with MG132 and clasto-lactacystin
-lactone (Fig. 1C). Exposures to heat shock (4 h) and hemin (16 h)
resulted in equal increases in Hsp70 levels (Fig. 1C). The amounts of
Hsp90 and Hsc70 were not affected by these treatments.
To gain insight to the regulatory mechanism of heat shock response upon
proteasome down-regulation, the HSF1 and HSF2 proteins were analyzed by
Western blotting. As shown in Fig. 1D, no changes in HSF1 protein
levels were observed in response to treatment with the proteasome
inhibitors. However, heat shock, MG132, and clasto-lactacystin
-lactone, but not hemin, induced
hyperphosphorylation of HSF1 (Fig. 1D), which can be detected by the
appearance of slower-migrating HSF1 bands resulting from induced
phosphorylation (7, 14, 35). HSF2 protein levels were
dramatically increased in MG132 and clasto-lactacystin
-lactone-treated cells by 3 h, whereas heat shock had no effect
on HSF2 (Fig. 1D). Hemin treatment increased HSF2 levels, but with
different kinetics compared to MG132. By 8 h, the HSF2 protein
levels were slightly elevated and thereafter the amounts of HSF2
continued to increase (Fig. 1D). The increase in HSF2 protein was due
solely to inhibited proteasome function, as HSF2 mRNA levels did not
increase in MG132-treated K562 cells (Fig. 1E). In contrast, consistent
with the transcriptional induction of hsp70 gene shown in
Fig. 1B, the hsp70 mRNA amounts dramatically increased after
2 h of MG132 treatment and continued to increase during the 8-h
period (Fig. 1E).
Heat shock response induced by proteasome inhibition requires
HSF1.
Since down-regulation of the proteasome function induced HSF
HSE-binding activity and heat shock gene transcription, and both HSF1
and HSF2 were affected, it was important to establish the specific
roles of these transcriptional regulators by using two strategies that
abrogated HSF1 and HSF2 activities. First, we studied the effect of
proteasome inhibition on HSF2 activity by using K562 cell clones stably
overexpressing either the HSF2-
(2
-C7) or HSF2-
(2
-D5)
isoform. Overexpression of HSF2-
has an enhancing effect on
activation of HSF2, whereas overexpression of the dominant negative
HSF2-
isoform prevents HSF2 activation (17). As shown in
Fig. 2, both 1-h heat shock and 3-h MG132 treatments induced equivalent
HSF HSE binding in cells expressing either HSF2-
or HSF2-
and in
mock-transfected cells (Fig. 2). In
contrast, no HSF HSE binding was detected in 2
-D5 cells upon hemin
treatment (Fig. 2) (17).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
Proteasome inhibition induces HSF HSE binding in the
absence of HSF2 activity. Whole cell extracts from control (C),
heat-shocked (HS; 42°C for 1 h), hemin-treated (He; 40 µM for
16 h), and MG132-treated (MG; 10 µM for 3 h)
mock-transfected K562 cells (vector) or K562 cells overexpressing the
HSF2- (2 -C7) or HSF2- (2 -D5) isoform were analyzed as for
Fig. 1A.
|
|
To elucidate the role of HSF1 during the heat shock response induced by
proteasome inhibition, we investigated the effect of MG132 on HSF1 and
HSF2 in wild-type and hsf1
/
MEF cells
(24). Both heat shock and MG132 treatments strongly induced
HSF HSE binding in wild-type cells, whereas in the HSF1-deficient cells, treatment with MG132 induced only a modest HSF HSE-binding activity (Fig. 3A), which was perturbed
with anti-
-HSF2 antibody (data not shown). Similar results were
obtained with clasto-lactacystin
-lactone (data not
shown). As expected, heat shock did not activate HSF HSE binding in the
hsf1
/
cells (Fig. 3A) (24).

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 3.
HSF1, but not HSF2, can restore Hsp70 expression. (A)
Whole cell extracts from control (C), heat-shocked (HS; 42°C for
1 h without [1] or with [R] a 3-h recovery at 37°C), and
MG132-treated (10 µM for 3 and 8 h) wild-type (+/+) and
hsf1 / MEF cells, as well as wild-type and
hsf1 / cells transiently transfected with
mouse HSF1 (+ HSF1), were analyzed as described for Fig. 1A. (B) The
samples described above were analyzed by SDS-PAGE and immunoblotted
with antibodies against HSF1, HSF2, Hsp70, Hsp90, Hsc70, and actin. (C)
Whole cell extracts from control (C), heat-shocked (HS; 42°C for
1 h without [1] or with [R] a 3-h recovery at 37°C), and
MG132-treated (10 µM for 8 h) MEF cells deficient for HSF1, as
well as hsf1 / cells transiently transfected
with mouse HSF2 (+ HSF2) or HSF1 (+ HSF1), were subjected to gel
mobility shift analysis (upper panels) and Western immunoblotting
(lower panels) using antibodies against HSF2, HSF1, Hsp70, and actin.
(D) Whole cell extracts from control (C) and MG132-treated (10 µM for
8 h) hsf1 / cells transiently
transfected with Flag epitope-tagged mouse HSF1 (+ HSF1) and HSF2 (+ HSF2) were subjected to Western immunoblotting using antibodies against
HSF1, HSF2, Flag, Hsp70, and Hsc70.
|
|
Expression of Hsp70 in HSF1-deficient cells can be rescued by
exogenous HSF1.
To further analyze whether HSF1 is the main
regulator of heat shock gene expression during down-regulation of
proteasome activity, mouse HSF1 was reintroduced into wild-type and
hsf1
/
MEF cells by transient transfection.
In both cases, overexpression of HSF1 induced a basal HSF HSE-binding
activity (Fig. 3A). Heat shock for 1 h further increased the HSF
HSE-binding activity, and after a 3-h recovery at normal temperature,
the HSE-binding activity was decreased to the basal level.
Interestingly, upon 3 h of MG132 treatment, the HSF HSE-binding
activity was similarly increased when exogenous HSF1 was expressed in
wild-type cells and in cells deficient for HSF1, and the HSE-binding
activity was further enhanced by 8 h of MG132 treatment (Fig. 3A).
As shown in Fig. 3B, both wild-type and
hsf1
/
cells expressed significant amounts of
the exogenous HSF1, and a 1-h heat shock and 3- to 8-h MG132 treatment
resulted in an altered phosphorylation state of HSF1. However, in
contrast to heat shock, which induced hyperphosphorylation of HSF1,
more intermediate phosphorylation forms were detected in response to
blocked proteasome function. Despite the significant increase in HSF2
protein levels after 3 h of MG132 treatment in both wild-type and
HSF1-deficient MEF cells (Fig. 3B), only a minor HSF2 HSE-binding
activity was detected in hsf1
/
cells (Fig.
3A). The Hsp70 protein levels were strongly increased after a 1-h heat
shock followed by a 3-h recovery and after an 8-h MG132 treatment in
wild-type MEF cells. In contrast, in HSF1-deficient cells, no Hsp70
protein was detected, although the endogenous HSF2 protein levels were
equal in both wild-type and hsf1
/
cells
(Fig. 3B).
Strikingly, reintroduction of the mouse HSF1 gene into the
hsf1
/
cells fully restored the Hsp70
expression in response to heat shock and inhibition of the ubiquitin
proteolytic pathway. Overexpression of HSF1 did not markedly affect
Hsp70 protein levels in wild-type cells (Fig. 3B). Equivalent
expression of Hsp90 and Hsc70 was present in both wild-type cells and
in HSF1-deficient cells, and overexpression of HSF1 did not affect the
levels of these proteins (Fig. 3B). To compare the effects of exogenous
HSF1 and HSF2 on Hsp70 expression upon exposure to heat shock or
inhibition of proteasome function, we transiently transfected
hsf1
/
cells with the mouse HSF2. In contrast
to the spontaneous DNA-binding activity in HSF1-transfected cells,
overexpression of HSF2 caused neither basal nor inducible HSF HSE
binding (Fig. 3C, upper panels). Despite overexpression of HSF2, Hsp70
expression could not be restored in hsf1
/
cells treated with the proteasome inhibitors or heat shock (Fig. 3C,
lower panels). To compare the relative expression levels of exogenous
HSF1 and HSF2, we repeated the previous experiment by using Flag
epitope-tagged forms of HSF1 and HSF2. As shown in Fig. 3D, the
antibody specific for the Flag epitope revealed equivalent expression
levels of the transfected genes, and Hsp70 expression was rescued only
by HSF1, thereby verifying the results in Fig. 3B and C.
 |
DISCUSSION |
Originally identified by their increased expression
following heat shock, Hsp70 proteins function as molecular chaperones that assist protein folding processes in most cellular compartments (4, 10, 20, 28). Apart from the well-characterized
heat-induced stress response mediated by HSF1 (25, 42),
regulation of the inducible Hsp70 expression during nonstressful
conditions and certain pathophysiological states is largely unknown.
Using a gain-of-function strategy in HSF1-deficient cells, we have
established the absolute requirement of HSF1 in the regulation of
hsp70 gene expression in the ubiquitin-proteasome network.
Our findings are summarized in the following model of Hsp70 induction
upon proteasome inhibition (Fig. 4).
Down-regulation of the ubiquitin-proteasome pathway results in
increased amounts of polyubiquitinated proteins (6), which
in turn lead to HSF1 activation and HSF1-dependent hsp70
transcription (this study). According to the model, we anticipate that
by associating with the aberrant proteins targeted for degradation, Hsp70 and other molecular chaperones promote the cellular survival by
preventing protein aggregation and facilitating refolding. Most
importantly, although accumulation and partial oligomerization of HSF2
can be observed, HSF2, or other HSFs, cannot functionally substitute
for HSF1 during down-regulation of the ubiquitin-proteasome pathway.
The proposed model does not exclude the possible existence of a
positive regulator of HSF1 (45) or a negative regulator of
HSF2 (44).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Model of HSF1-dependent Hsp70 induction in the ubiquitin
(Ub)-proteasome pathway. Down-regulation of ubiquitin-mediated
proteolysis by proteasome inhibitors, such as MG132 and
clasto-lactacystin -lactone, results in the accumulation
of malfolded, abnormal, and short-lived proteins normally degraded by
the 26S proteasome (6). Increase in the amount of
polyubiquitinated proteins leads to oligomerization, phosphorylation,
and acquisition of HSF1 HSE-binding activity, which in turn induces
hsp70 transcription and accumulation of the Hsp70 protein,
leading to enhanced molecular chaperone activity. It can be speculated
that by associating with the polyubiquitinated proteins, molecular
chaperones, among them Hsp70, promote the cellular survival by
preventing protein aggregation and facilitating the malfolded proteins
to refold. On the other hand, proteasome inhibition results in
accumulation and partial oligomerization of the labile HSF2 protein,
but the specific role of HSF2 under these conditions remains to be
elucidated.
|
|
The signal for HSF1 activation upon inhibition of the
ubiquitin-proteasome pathway most probably results from the
accumulation of undegraded, unfolded, and misfolded proteins.
Interestingly, this kind of protein deposition has been implicated in
disease pathogenesis of a number of chronic degenerative diseases, such as cystic fibrosis, Alzheimer's disease, Cushing's disease, and amyotrophic lateral sclerosis (6, 12), all of which exhibit abnormal proteins that accumulate either inside or outside of the cell.
Whether the increased levels of Hsp70 and other Hsps observed in some
of the degenerative diseases are dependent on HSF1 is an important
question for future studies. Another aspect of Hsp accumulation is
thermotolerance, which can be acquired by induction of Hsps in response
to mild heat stress (19, 29). Thermotolerance is an
endogenous mechanism for cells to withstand subsequent greater thermal
injury, and in addition to hyperthermia, the beneficial effects of
acquired thermotolerance could protect against injury from other forms
of noxious stimuli (cross-tolerance). Alternatively, pharmacological
strategies such as pretreatment with the proteasome inhibitor MG132 for
as little as 2 h markedly increase the survival of cells subjected
to high temperatures, thus conferring cross-tolerance (5,
16). Our finding that HSF1 is indispensable for the inducible
expression of Hsp70 upon treatment with MG132 and other proteasome
inhibitors is likely of importance in understanding the regulation of
cytoprotection and discovering its potential medical applications.
The physiological role of two structurally highly related HSFs, HSF1
and HSF2, and their specific functions in the regulation of heat shock
gene expression have remained unresolved. Here we demonstrate that the
increase in HSF2 expression does not correspond to the enhanced Hsp70
expression, as neither accumulation of the endogenous HSF2 protein in
response to blocked proteasome function nor overexpression of the
exogenous HSF2 prior to inhibition of proteasome function induces Hsp70
expression. Furthermore, HSF2 is not capable of compensating for HSF1
in the physiological heat shock response or acquired thermotolerance,
as demonstrated with MEF cells derived from HSF1-deficient mice
(24). It has been proposed that HSF2 might have other target
genes, such as the thioredoxin gene (18, 31), and during
development no correlation between activation of HSF2 and expression of
heat shock genes has been observed (1, 33). Abundant
expression of Hsp70 in K562 cells undergoing hemin-mediated erythroid
differentiation was originally shown to be due to HSF2 activation
(38, 39). Also, HSF1 has been reported to mediate
hemin-induced hsp70 expression (44). However, our
recent studies suggest that the antibody supershift technique used in
these studies is not adequate for determining the composition of
HSF-HSE complexes (30), stressing the usefulness of the
knockout cells as experimental tools.
Under normal cellular as well as stressful conditions, cells must
continuously use both reparative and degradative pathways to cope with
the accumulation of abnormal proteins. It has been speculated that
enzymes of the ubiquitin-conjugating system are assisted by Hsp70 and
other molecular chaperones in their task to identify proteins with
nonnative conformation (8, 36). The high cross-species
conservation of the components of cellular stress response machinery,
including the 26S proteasome complex, reflects the need for effective
degradation of damaged proteins. It is plausible that the decreased
rate of macromolecular degradation is a signal for HSF1 activation,
resulting in beneficial effects on protein homeostasis by increasing
the concentration of thermoprotectant molecules and molecular chaperones.
 |
ACKNOWLEDGMENTS |
The first two authors contributed equally to this work.
We thank Helena Saarento and Päivi Nykänen for excellent
technical assistance, and we thank John E. Eriksson and Marko Kallio for valuable comments and discussions.
This work was supported by the Academy of Finland, the Sigrid
Jusélius Foundation, and the Finnish Cancer Organizations (L.S.), by the Finnish Medical Society DUODECIM (T.-P.A.), and by the Emil
Aaltonen Foundation (L.P.). L.P. and T.-P.A. are supported by the Turku
Graduate School of Biomedical Sciences. I.J.B. received support from
the National Institutes of Health (K14 award, grant HL60667) and an
Established Investigator Award from the American Heart Association.
 |
FOOTNOTES |
*
Corresponding author. Mailing address for Lea Sistonen:
Turku Centre for Biotechnology, P.O. Box 123, FIN-20521 Turku, Finland. Phone: 358-2-3338028. Fax: 358-2-3338000. E-mail:
lea.sistonen{at}btk.utu.fi. Mailing address for Ivor J. Benjamin: Department of Internal Medicine, University of Texas
Southwestern Medical Center, 5323 Harry Hines Blvd. NB11.110,
Dallas, TX 75235-8573. Phone: (214) 648-1405. Fax: (214) 648-1475. E-mail: ivor.benjamin{at}emailswmed.edu.
 |
REFERENCES |
| 1.
|
Alastalo, T.-P.,
M. Lönnström,
S. Leppä,
K. Kaarniranta,
M. Pelto-Huikko,
L. Sistonen, and M. Parvinen.
1998.
Stage-specific expression and cellular localization of the heat shock factor 2 isoforms in the rat seminiferous epithelium.
Exp. Cell Res.
240:16-27[CrossRef][Medline].
|
| 2.
|
Baler, R.,
G. Dahl, and R. Voellmy.
1993.
Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1.
Mol. Cell. Biol.
13:2486-2496[Abstract/Free Full Text].
|
| 3.
|
Banerji, S. S.,
N. G. Theodorakis, and R. I. Morimoto.
1984.
Heat shock-induced translational control of HSP70 and globin synthesis in chicken reticulocytes.
Mol. Cell. Biol.
4:2437-2448[Abstract/Free Full Text].
|
| 4.
|
Bukau, B., and A. L. Horwich.
1998.
The Hsp70 and Hsp60 chaperone machines.
Cell
92:351-366[CrossRef][Medline].
|
| 5.
|
Bush, K. T.,
A. L. Goldberg, and S. K. Nigam.
1997.
Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance.
J. Biol. Chem.
272:9086-9092[Abstract/Free Full Text].
|
| 6.
|
Ciechanover, A.
1998.
The ubiquitin-proteasome pathway: on protein death and cell life.
EMBO J.
17:7151-7160[CrossRef][Medline].
|
| 7.
|
Cotto, J. J.,
M. Kline, and R. I. Morimoto.
1996.
Activation of heat shock factor 1 DNA binding precedes stress-induced serine phosphorylation.
J. Biol. Chem.
271:3355-3358[Abstract/Free Full Text].
|
| 8.
|
Craig, E. A.,
B. K. Baxter,
J. Becker,
J. Halladay, and T. Ziegelhoffer.
1994.
Cytosolic hsp70s of Saccharomyces cerevisiae: roles in protein synthesis, protein translocation, proteolysis, and regulation, p. 31-52.
In
R. I. Morimoto, A. Tissières, and C. Georgopoulos (ed.), The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 9.
|
Fort, P.,
L. Marty,
M. Piechaczyk,
S. El Sabrouty,
C. Dani,
P. Jeanteur, and J. M. Blanchard.
1985.
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family.
Nucleic Acids Res.
13:1431-1442[Abstract/Free Full Text].
|
| 10.
|
Hartl, F. U.
1996.
Molecular chaperones in cellular protein folding.
Nature
381:571-580[CrossRef][Medline].
|
| 11.
|
Hickey, E.,
S. E. Brandon,
G. Smale,
D. Lloyd, and L. A. Weber.
1989.
Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein.
Mol. Cell. Biol.
9:2615-2626[Abstract/Free Full Text].
|
| 12.
|
Kaufman, R. J.
1999.
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls.
Genes Dev.
13:1211-1233[Free Full Text].
|
| 13.
|
Kawazoe, Y.,
A. Nakai,
M. Tanabe, and K. Nagata.
1998.
Proteasome inhibition leads to the activation of all members of the heat-shock-factor family.
Eur. J. Biochem.
255:356-362[Medline].
|
| 14.
|
Kim, D.,
S. H. Kim, and G. C. Li.
1999.
Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression.
Biochem. Biophys. Res. Commun.
254:264-268[CrossRef][Medline].
|
| 15.
|
Lee, D. H., and A. L. Goldberg.
1998.
Proteasome inhibitors: valuable new tools for cell biologists.
Trends Cell Biol.
8:397-403[CrossRef][Medline].
|
| 16.
|
Lee, D. H., and A. L. Goldberg.
1998.
Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae.
Mol. Cell. Biol.
18:30-38[Abstract/Free Full Text].
|
| 17.
|
Leppä, S.,
L. Pirkkala,
H. Saarento,
K. D. Sarge, and L. Sistonen.
1997.
Overexpression of HSF2- inhibits hemin-induced heat shock gene expression and erythroid differentiation in K562 cells.
J. Biol. Chem.
272:15293-15298[Abstract/Free Full Text].
|
| 18.
|
Leppä, S.,
L. Pirkkala,
S. C. Chow,
J. E. Eriksson, and L. Sistonen.
1997.
Thioredoxin is transcriptionally induced upon activation of heat shock factor 2.
J. Biol. Chem.
272:30400-30404[Abstract/Free Full Text].
|
| 19.
|
Li, G. C., and A. Nussenzweig.
1996.
Thermotolerance and heat shock proteins: possible involvement of Ku autoantigen in regulating HSP70 expression, p. 425-449.
In
U. Feige, R. I. Morimoto, I. Yahara, and B. S. Polla (ed.), Stress-inducible cellular responses. Birkhäuser Verlag, Basel, Switzerland.
|
| 20.
|
Lindquist, S., and E. A. Craig.
1988.
The heat shock response.
Annu. Rev. Genet.
22:631-677[CrossRef][Medline].
|
| 21.
|
Mathew, A.,
S. K. Mathur, and R. I. Morimoto.
1998.
The heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway.
Mol. Cell. Biol.
18:5091-5098[Abstract/Free Full Text].
|
| 22.
|
Meriin, A. B.,
V. L. Gabai,
J. Yaglom,
V. I. Shifrin, and M. Y. Sherman.
1998.
Proteasome inhibitors activate stress kinases and induce Hsp72.
J. Biol. Chem.
273:6373-6379[Abstract/Free Full Text].
|
| 23.
|
Mezger, V.,
M. Rallu,
R. I. Morimoto,
M. Morange, and J.-P. Renard.
1994.
Heat shock factor 2-like activity in mouse blastocysts.
Dev. Biol.
166:819-822[CrossRef][Medline].
|
| 24.
|
McMillan, D. R.,
X. Xiao,
L. Shao,
K. Graves, and I. J. Benjamin.
1998.
Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis.
J. Biol. Chem.
273:7523-7528[Abstract/Free Full Text].
|
| 25.
|
Morimoto, R. I.
1998.
Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators.
Genes Dev.
12:3788-3796[Free Full Text].
|
| 26.
|
Mosser, D. D.,
N. G. Theodorakis, and R. I. Morimoto.
1988.
Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells.
Mol. Cell. Biol.
8:4736-4744[Abstract/Free Full Text].
|
| 27.
|
Nakai, A.,
M. Tanabe,
Y. Kawazoe,
J. Inazawa,
R. I. Morimoto, and K. Nagata.
1997.
HSF4, a new member of the human heat shock family which lacks properties of a transcriptional activator.
Mol. Cell. Biol.
17:469-481[Abstract].
|
| 28.
|
Netzer, W. J., and F. U. Hartl.
1998.
Protein folding in the cytosol: chaperonin-dependent and -independent mechanisms.
Trends Biochem. Sci.
23:68-73[CrossRef][Medline].
|
| 29.
|
Parsell, D. A., and S. Lindquist.
1994.
Heat shock proteins and stress tolerance, p. 457-494.
In
R. I. Morimoto, A. Tissières, and C. Georgopoulos (ed.), The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 30.
|
Pirkkala, L., and L. Sistonen.
1999.
Antibody supershift assay is inadequate for determining HSF stoichiometry in HSE complexes.
Cell Stress Chaperones
4:259-261[CrossRef][Medline].
|
| 31.
|
Pirkkala, L.,
T.-P. Alastalo,
P. Nykänen,
L. Seppä, and L. Sistonen.
1999.
Differentiation lineage-specific expression of human heat shock transcription factor 2.
FASEB J.
13:1089-1098[Abstract/Free Full Text].
|
| 32.
|
Rabindran, S. K.,
G. Giorgi,
J. Clos, and C. Wu.
1991.
Molecular cloning and expression of a human heat shock factor, HSF1.
Proc. Natl. Acad. Sci. USA
88:6906-6910[Abstract/Free Full Text].
|
| 33.
|
Rallu, M.,
M. T. Loones,
Y. Lallemand,
R. I. Morimoto,
M. Morange, and V. Mezger.
1997.
Function and regulation of heat shock factor 2 during mouse embryogenesis.
Proc. Natl. Acad. Sci. USA
94:2392-2397[Abstract/Free Full Text].
|
| 34.
|
Sarge, K. D.,
V. Zimarino,
K. Holm,
C. Wu, and R. I. Morimoto.
1991.
Cloning and characterization of two mouse heat shock factors with distinct inducible and constitutive DNA-binding ability.
Genes Dev.
5:1902-1911[Abstract/Free Full Text].
|
| 35.
|
Sarge, K. D.,
S. P. Murphy, and R. I. Morimoto.
1993.
Activation of heat shock gene transcription by HSF1 involves oligomerization, acquisition of DNA binding activity, and nuclear localization and can occur in the absence of stress.
Mol. Cell. Biol.
13:1392-1407[Abstract/Free Full Text].
|
| 36.
|
Scheffner, M.,
S. Smith, and S. Jentsch.
1998.
The ubiquitin-conjugation system, p. 65-98.
In
J.-M. Peters, J. R. Harris, and D. Finley (ed.), Ubiquitin and the biology of the cell. Plenum Press, New York, N.Y.
|
| 37.
|
Schuetz, T. J.,
G. J. Gallo,
L. Sheldon,
P. Tempst, and R. E. Kingston.
1991.
Isolation of a cDNA for HSF2: evidence for two heat shock factor genes in humans.
Proc. Natl. Acad. Sci. USA
88:6911-6915[Abstract/Free Full Text].
|
| 38.
|
Sistonen, L.,
K. D. Sarge,
B. Phillips,
K. Abravaya, and R. I. Morimoto.
1992.
Activation of heat shock factor 2 during hemin-induced differentiation of human erythroleukemia cells.
Mol. Cell. Biol.
12:4104-4111[Abstract/Free Full Text].
|
| 39.
|
Sistonen, L.,
K. D. Sarge, and R. I. Morimoto.
1994.
Human heat shock factors 1 and 2 are differentially activated and can synergistically induce hsp70 gene transcription.
Mol. Cell. Biol.
14:2087-2099[Abstract/Free Full Text].
|
| 40.
|
Theodorakis, N. G.,
D. J. Zand,
P. T. Kotzbauer,
G. T. Williams, and R. I. Morimoto.
1989.
Hemin-induced transcriptional activation of the hsp70 gene during erythroid maturation in K562 cells is due to a heat shock factor-mediated stress response.
Mol. Cell. Biol.
9:3166-3173[Abstract/Free Full Text].
|
| 41.
|
Wu, B.,
C. Hunt, and R. I. Morimoto.
1985.
Structure and expression of the human gene encoding major heat shock protein HSP70.
Mol. Cell. Biol.
5:330-341[Abstract/Free Full Text].
|
| 42.
|
Wu, C.
1995.
Heat shock transcription factors: structure and regulation.
Annu. Rev. Cell Dev. Biol.
11:441-469[CrossRef][Medline].
|
| 43.
|
Xiao, X.,
X. Zuo,
A. A. Davis,
D. R. McMillan,
B. B. Curry,
J. A. Richardson, and I. J. Benjamin.
1999.
HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice.
EMBO J.
18:5943-5952[CrossRef][Medline].
|
| 44.
|
Yoshima, T.,
T. Yura, and H. Yanagi.
1998.
Heat shock factor 1 mediates hemin-induced hsp70 gene transcription in K562 erythroleukemia cells.
J. Biol. Chem.
273:25466-25471[Abstract/Free Full Text].
|
| 45.
|
Zhou, M.,
X. Wu, and H. N. Ginsberg.
1996.
Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cells.
J. Biol. Chem.
271:24769-24775[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 2000, p. 2670-2675, Vol. 20, No. 8
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
AKERFELT, M., TROUILLET, D., MEZGER, V., SISTONEN, L.
(2007). Heat Shock Factors at a Crossroad between Stress and Development. Ann. N. Y. Acad. Sci.
1113: 15-27
[Abstract]
[Full Text]
-
Boyault, C., Zhang, Y., Fritah, S., Caron, C., Gilquin, B., Kwon, S. H., Garrido, C., Yao, T.-P., Vourc'h, C., Matthias, P., Khochbin, S.
(2007). HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev.
21: 2172-2181
[Abstract]
[Full Text]
-
Ostling, P., Bjork, J. K., Roos-Mattjus, P., Mezger, V., Sistonen, L.
(2007). Heat Shock Factor 2 (HSF2) Contributes to Inducible Expression of hsp Genes through Interplay with HSF1. J. Biol. Chem.
282: 7077-7086
[Abstract]
[Full Text]
-
Seo, H. R., Chung, D.-Y., Lee, Y.-J., Lee, D.-H., Kim, J.-I., Bae, S., Chung, H.-Y., Lee, S.-J., Jeoung, D., Lee, Y.-S.
(2006). Heat Shock Protein 25 or Inducible Heat Shock Protein 70 Activates Heat Shock Factor 1: DEPHOSPHORYLATION ON SERINE 307 THROUGH INHIBITION OF ERK1/2 PHOSPHORYLATION. J. Biol. Chem.
281: 17220-17227
[Abstract]
[Full Text]
-
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J. Jr, Lee, K. P., Boise, L. H.
(2006). Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood
107: 4907-4916
[Abstract]
[Full Text]
-
Anckar, J., Hietakangas, V., Denessiouk, K., Thiele, D. J., Johnson, M. S., Sistonen, L.
(2006). Inhibition of DNA Binding by Differential Sumoylation of Heat Shock Factors. Mol. Cell. Biol.
26: 955-964
[Abstract]
[Full Text]
-
Hietakangas, V., Anckar, J., Blomster, H. A., Fujimoto, M., Palvimo, J. J., Nakai, A., Sistonen, L.
(2006). PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. USA
103: 45-50
[Abstract]
[Full Text]
-
Awasthi, N., Wagner, B. J.
(2005). Upregulation of Heat Shock Protein Expression by Proteasome Inhibition: An Antiapoptotic Mechanism in the Lens. IOVS
46: 2082-2091
[Abstract]
[Full Text]
-
Wang, X., Wang, F., Sy, M.-S., Ma, J.
(2005). Calpain and Other Cytosolic Proteases Can Contribute to the Degradation of Retro-translocated Prion Protein in the Cytosol. J. Biol. Chem.
280: 317-325
[Abstract]
[Full Text]
-
Wang, Y., Theriault, J. R., He, H., Gong, J., Calderwood, S. K.
(2004). Expression of a Dominant Negative Heat Shock Factor-1 Construct Inhibits Aneuploidy in Prostate Carcinoma Cells*. J. Biol. Chem.
279: 32651-32659
[Abstract]
[Full Text]
-
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., McLean, P. J.
(2004). Hsp70 Reduces {alpha}-Synuclein Aggregation and Toxicity. J. Biol. Chem.
279: 25497-25502
[Abstract]
[Full Text]
-
Mimnaugh, E. G., Xu, W., Vos, M., Yuan, X., Isaacs, J. S., Bisht, K. S., Gius, D., Neckers, L.
(2004). Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Molecular Cancer Therapeutics
3: 551-566
[Abstract]
[Full Text]
-
Alastalo, T.-P., Hellesuo, M., Sandqvist, A., Hietakangas, V., Kallio, M., Sistonen, L.
(2003). Formation of nuclear stress granules involves HSF2 and coincides with the nucleolar localization of Hsp70. J. Cell Sci.
116: 3557-3570
[Abstract]
[Full Text]
-
Hietakangas, V., Ahlskog, J. K., Jakobsson, A. M., Hellesuo, M., Sahlberg, N. M., Holmberg, C. I., Mikhailov, A., Palvimo, J. J., Pirkkala, L., Sistonen, L.
(2003). Phosphorylation of Serine 303 Is a Prerequisite for the Stress-Inducible SUMO Modification of Heat Shock Factor 1. Mol. Cell. Biol.
23: 2953-2968
[Abstract]
[Full Text]
-
McMillan, D. R., Christians, E., Forster, M., Xiao, X., Connell, P., Plumier, J.-C., Zuo, X., Richardson, J., Morgan, S., Benjamin, I. J.
(2002). Heat Shock Transcription Factor 2 Is Not Essential for Embryonic Development, Fertility, or Adult Cognitive and Psychomotor Function in Mice. Mol. Cell. Biol.
22: 8005-8014
[Abstract]
[Full Text]
-
Boone, A. N., Vijayan, M. M.
(2002). Glucocorticoid-mediated attenuation of the hsp70 response in trout hepatocytes involves the proteasome. Am. J. Physiol. Regul. Integr. Comp. Physiol.
283: R680-R687
[Abstract]
[Full Text]
-
Ahn, S.-G., Liu, P. C.C., Klyachko, K., Morimoto, R. I., Thiele, D. J.
(2001). The loop domain of heat shock transcription factor 1 dictates DNA-binding specificity and responses to heat stress. Genes Dev.
15: 2134-2145
[Abstract]
[Full Text]
-
PIRKKALA, L., NYKANEN, P., SISTONEN, L.
(2001). Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J.
15: 1118-1131
[Abstract]
[Full Text]
-
Peng, Z., Staub, J. M., Serino, G., Kwok, S. F., Kurepa, J., Bruce, B. D., Vierstra, R. D., Wei, N., Deng, X.-W.
(2001). The Cellular Level of PR500, a Protein Complex Related to the 19S Regulatory Particle of the Proteasome, Is Regulated in Response to Stresses in Plants. Mol. Biol. Cell
12: 383-392
[Abstract]
[Full Text]
-
Xu, Q., Schett, G., Li, C., Hu, Y., Wick, G.
(2000). Mechanical Stress-Induced Heat Shock Protein 70 Expression in Vascular Smooth Muscle Cells Is Regulated by Rac and Ras Small G Proteins but Not Mitogen-Activated Protein Kinases. Circ. Res.
86: 1122-1128
[Abstract]
[Full Text]